Literature DB >> 18626615

[Cutaneous larva migrans].

N-P Hoff1, R Mota, A Groffik, U R Hengge.   

Abstract

As a result of the rise of mass tourism with increasingly cheap and exotic destinations, tropical diseases are becoming an increasingly important part of dermatology. Infection with cutaneous larva migrans is one of the most common "souvenirs" from the tropics. The disease is caused by the nematode infection with dog or cat hookworm parasites (Ancylostoma braziliense or A. caninum). The characteristic manifestation is a gyrated, serpiginous and in some cases vesicular erythema, which appears after penetration of the epidermis by the parasite and the subsequent intraepidermal migration of the larva. This is often accompanied by intense pruritus in the affected skin. The infection is usually found in those areas of the foot, calf or buttocks exposed by walking or sitting on sand. Although subjectively very unpleasant, the disease is self-limiting and resolves after several weeks; it is treated locally in most cases (e.g. using cryotherapy). The prognosis of the disease is excellent, but a prolonged course or complications have been observed, e.g. due to superinfection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626615     DOI: 10.1007/s00105-008-1514-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

1.  Effectiveness of a new therapeutic regimen with albendazole in cutaneous larva migrans.

Authors:  S Veraldi; G Rizzitelli
Journal:  Eur J Dermatol       Date:  1999 Jul-Aug       Impact factor: 3.328

Review 2.  Cutaneous larva migrans: the creeping eruption.

Authors:  Marc A Brenner; Mital B Patel
Journal:  Cutis       Date:  2003-08

3.  THIABENDAZOLE EFFECTIVENESS IN CREEPING ERUPTION.

Authors:  O J STONE; J F MULLINS
Journal:  Arch Dermatol       Date:  1965-05

4.  Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics.

Authors:  Mogens Jensenius; Arild Maeland; Oddbjørn Brubakk
Journal:  Travel Med Infect Dis       Date:  2007-11-05       Impact factor: 6.211

5.  [Treatment of the cutaneous larva migrans syndrome "Larbish" with albendazole. Apropos of 18 cases].

Authors:  J P Coulaud; D Binet; C Voyer; C Samson; G Moreau; J F Rossignol
Journal:  Bull Soc Pathol Exot Filiales       Date:  1982-11

6.  Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller.

Authors:  V Blackwell; F Vega-Lopez
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

7.  Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit.

Authors:  E Caumes; J Carrière; G Guermonprez; F Bricaire; M Danis; M Gentilini
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

8.  Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans.

Authors:  P J Hotez; S Narasimhan; J Haggerty; L Milstone; V Bhopale; G A Schad; F F Richards
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans.

Authors:  E Caumes; J Carriere; A Datry; P Gaxotte; M Danis; M Gentilini
Journal:  Am J Trop Med Hyg       Date:  1993-11       Impact factor: 2.345

10.  Larva migrans complicated by Loeffler's syndrome.

Authors:  M A Guill; R B Odom
Journal:  Arch Dermatol       Date:  1978-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.